Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

799
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
799
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

865
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
865

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping Individualized Dual-Axis Network Topology in Focal Epilepsy: Divergent Alterations in System Integrity, Integration, and Clinical Correlates.

bioRxiv : the preprint server for biology·2026
Same author

Structural and Functional Connectivity Predict the Effects of Direct Brain Stimulation on Memory.

bioRxiv : the preprint server for biology·2026
Same author

Thalamic organization differentially contributes to clinical conditions in epilepsy.

Communications medicine·2026
Same author

Treatment approaches in posthypoxic myoclonus: A narrative review with expert opinion.

Epilepsia·2025
Same author

Potential for Therapeutic Alteration of the Underlying Biology of Epilepsy.

Biomedicines·2025
Same author

Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity.

Neurology·2025
Same journal

Semiology of functional/dissociative seizures in idiopathic generalized epilepsy: An inpatient video-electroencephalographic study.

Epilepsia·2026
Same journal

Perineuronal net abnormalities in epileptic human tissue.

Epilepsia·2026
Same journal

Cortical stimulation reveals effective disconnection of the epileptogenic network at seizure onset.

Epilepsia·2026
Same journal

Anterior cingulate cortex neuron subtypes differentially regulate seizures.

Epilepsia·2026
Same journal

Ultrafast oscillations in the human brain and their functional significance.

Epilepsia·2026
Same journal

Magnetoencephalographic source imaging improves localization of the epileptogenic zone in multimodal imaging evaluation.

Epilepsia·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

17.9K

Artificial intelligence for epilepsy decision support.

Itai Loushy1, Michael R Sperling1

  • 1Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Epilepsia
|November 21, 2025
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) offers significant potential in epilepsy care by improving diagnostic accuracy and treatment efficiency. Responsible adoption requires addressing ethical concerns and validating AI tools in real-world clinical settings.

Keywords:
artificial intelligenceepilepsyhealth care automationmachine learning

More Related Videos

A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery
09:41

A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery

Published on: May 20, 2016

12.7K
Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring
11:28

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring

Published on: June 13, 2025

1.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

17.9K
A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery
09:41

A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery

Published on: May 20, 2016

12.7K
Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring
11:28

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring

Published on: June 13, 2025

1.2K

Area of Science:

  • Neurology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Epilepsy diagnosis and treatment present challenges due to uncertainty and variability.
  • Artificial intelligence (AI) is emerging as a tool to address these complexities.
  • Current applications span diagnostics, treatment prediction, and workflow optimization.

Purpose of the Study:

  • To review the current and potential applications of AI in epilepsy management.
  • To highlight opportunities for AI in improving efficiency and diagnostic accuracy.
  • To discuss challenges and ethical considerations for responsible AI adoption.

Main Methods:

  • Review of AI applications in key epilepsy domains: history-taking, electronic records, EEG, MRI, and multimodal data.
  • Examination of AI's role in predicting seizure recurrence, drug resistance, and surgical candidacy.
  • Analysis of challenges in outcome measurement for epilepsy therapies and AI integration.

Main Results:

  • AI can enhance efficiency through task automation and improve diagnostic accuracy.
  • AI offers potential in predicting treatment response and surgical outcomes.
  • Ethical considerations including bias, transparency, and privacy are critical for AI implementation.

Conclusions:

  • AI shows promise as a decision-support tool to augment clinical judgment in epilepsy.
  • Validation in diverse real-world settings and clinician partnership are essential for responsible AI adoption.
  • Addressing ethical concerns is paramount for the successful integration of AI in epilepsy care.